AVEO Pharmaceuticals, Inc. (AVEO) in Focus: Stock Rises 7.8% - Tale of the Tape - ANI Pharmaceuticals (NASDAQ:ANIP)

AVEO Pharmaceuticals, Inc. AVEO was a big mover last session, as the company saw its shares rise nearly 8% on the day. This rally higher can be attributable to solid volume with far more shares changing hands than in a normal session. This stock, trading in a volatile price range of $1.02 to $1.21 in the past one-month time frame, showed a pick-up yesterday at $1.10.

The company has seen 2 positive estimate revisions in the past one month, while its Zacks Consensus Estimate of a loss narrowed over the same timeframe, suggesting that more solid trading could be ahead for the company. So make sure to keep an eye on this stock going forward to see if this recent move higher can last.

AVEO Pharmaceuticals currently has a Zacks Rank #3 (Hold) while its Earnings ESP is 0.00%.

Other players in the healthcare industry include Illumina Inc. ILMN, Gilead Sciences Inc. GILD and ANI Pharmaceuticals, Inc. ANIP all carrying a Zacks Rank #1 (Strong Buy).

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days.

Click to get this free report

AVEO PHARMACEUT AVEO: Free Stock Analysis Report

ILLUMINA INC ILMN: Free Stock Analysis Report

GILEAD SCIENCES GILD: Free Stock Analysis Report

ANI PHARMACEUT ANIP: Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research

Market News and Data brought to you by Benzinga APIs